Author(s)

Julie Taguchi, Christopher Duma, M. A. Nezami^*

Pacific Medical Center of Hope, Fresno, USA.

Concurrent dural and leptomeningeal metastatic carcinomatosis are very rare and have a poor prognosis. Here we present a woman with advanced estrogen receptor (ER) positive and progesterone receptor (PR) positive breast cancer who presented with leptomeningeal disease. Patient underwent multi targeted epigenetic therapies applied in a protocol called MTET. She continued to respond to the interval treatment, which consisted only of the nutraceutical agents. Here we discuss her case in detail and we believe that such an example might be applied to other patients in this situation resulting clinical improvement and less toxicity.

Breast Cancer, Metastatic, Leptomeningeal Disease, Dural Disease

Taguchi, J. , Duma, C. and Nezami, M. (2018) A Novel Combined Approach for Metastatic Breast Cancer with Dural and Leptomeningeal Disease with an Impressive Clinical Outcome: A Case Study. Journal of Cancer Therapy, 9, 274-280. doi: 10.4236/jct.2018.93025.